International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases

© 2017 The Author(s) Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their “diagnostic odyssey,” improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choi...

Full description

Bibliographic Details
Main Authors: Boycott, K., Rath, A., Chong, J., Hartley, T., Alkuraya, F., Baynam, Gareth, Brookes, A., Brudno, M., Carracedo, A., den Dunnen, J., Dyke, S., Estivill, X., Goldblatt, J., Gonthier, C., Groft, S., Gut, I., Hamosh, A., Hieter, P., Höhn, S., Hurles, M., Kaufmann, P., Knoppers, B., Krischer, J., Macek, M., Matthijs, G., Olry, A., Parker, S., Paschall, J., Philippakis, A., Rehm, H., Robinson, P., Sham, P., Stefanov, R., Taruscio, D., Unni, D., Vanstone, M., Zhang, F., Brunner, H., Bamshad, M., Lochmüller, H.
Format: Journal Article
Published: Cell Press 2017
Online Access:http://hdl.handle.net/20.500.11937/72942
_version_ 1848762882599157760
author Boycott, K.
Rath, A.
Chong, J.
Hartley, T.
Alkuraya, F.
Baynam, Gareth
Brookes, A.
Brudno, M.
Carracedo, A.
den Dunnen, J.
Dyke, S.
Estivill, X.
Goldblatt, J.
Gonthier, C.
Groft, S.
Gut, I.
Hamosh, A.
Hieter, P.
Höhn, S.
Hurles, M.
Kaufmann, P.
Knoppers, B.
Krischer, J.
Macek, M.
Matthijs, G.
Olry, A.
Parker, S.
Paschall, J.
Philippakis, A.
Rehm, H.
Robinson, P.
Sham, P.
Stefanov, R.
Taruscio, D.
Unni, D.
Vanstone, M.
Zhang, F.
Brunner, H.
Bamshad, M.
Lochmüller, H.
author_facet Boycott, K.
Rath, A.
Chong, J.
Hartley, T.
Alkuraya, F.
Baynam, Gareth
Brookes, A.
Brudno, M.
Carracedo, A.
den Dunnen, J.
Dyke, S.
Estivill, X.
Goldblatt, J.
Gonthier, C.
Groft, S.
Gut, I.
Hamosh, A.
Hieter, P.
Höhn, S.
Hurles, M.
Kaufmann, P.
Knoppers, B.
Krischer, J.
Macek, M.
Matthijs, G.
Olry, A.
Parker, S.
Paschall, J.
Philippakis, A.
Rehm, H.
Robinson, P.
Sham, P.
Stefanov, R.
Taruscio, D.
Unni, D.
Vanstone, M.
Zhang, F.
Brunner, H.
Bamshad, M.
Lochmüller, H.
author_sort Boycott, K.
building Curtin Institutional Repository
collection Online Access
description © 2017 The Author(s) Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their “diagnostic odyssey,” improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices. In a general clinical genetics setting, the current diagnostic rate is approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics evaluation, that rate is much lower. Diagnostic success for these more challenging affected individuals depends to a large extent on progress in the discovery of genes associated with, and mechanisms underlying, rare diseases. Thus, continued research is required for moving toward a more complete catalog of disease-related genes and variants. The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 to bring together researchers and organizations invested in rare disease research to develop a means of achieving molecular diagnosis for all rare diseases. Here, we review the current and future bottlenecks to gene discovery and suggest strategies for enabling progress in this regard. Each successful discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corresponding rare disease, enabling precision medicine for this patient population.
first_indexed 2025-11-14T10:54:38Z
format Journal Article
id curtin-20.500.11937-72942
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:54:38Z
publishDate 2017
publisher Cell Press
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-729422018-12-13T09:34:10Z International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases Boycott, K. Rath, A. Chong, J. Hartley, T. Alkuraya, F. Baynam, Gareth Brookes, A. Brudno, M. Carracedo, A. den Dunnen, J. Dyke, S. Estivill, X. Goldblatt, J. Gonthier, C. Groft, S. Gut, I. Hamosh, A. Hieter, P. Höhn, S. Hurles, M. Kaufmann, P. Knoppers, B. Krischer, J. Macek, M. Matthijs, G. Olry, A. Parker, S. Paschall, J. Philippakis, A. Rehm, H. Robinson, P. Sham, P. Stefanov, R. Taruscio, D. Unni, D. Vanstone, M. Zhang, F. Brunner, H. Bamshad, M. Lochmüller, H. © 2017 The Author(s) Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their “diagnostic odyssey,” improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices. In a general clinical genetics setting, the current diagnostic rate is approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics evaluation, that rate is much lower. Diagnostic success for these more challenging affected individuals depends to a large extent on progress in the discovery of genes associated with, and mechanisms underlying, rare diseases. Thus, continued research is required for moving toward a more complete catalog of disease-related genes and variants. The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 to bring together researchers and organizations invested in rare disease research to develop a means of achieving molecular diagnosis for all rare diseases. Here, we review the current and future bottlenecks to gene discovery and suggest strategies for enabling progress in this regard. Each successful discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corresponding rare disease, enabling precision medicine for this patient population. 2017 Journal Article http://hdl.handle.net/20.500.11937/72942 10.1016/j.ajhg.2017.04.003 Cell Press restricted
spellingShingle Boycott, K.
Rath, A.
Chong, J.
Hartley, T.
Alkuraya, F.
Baynam, Gareth
Brookes, A.
Brudno, M.
Carracedo, A.
den Dunnen, J.
Dyke, S.
Estivill, X.
Goldblatt, J.
Gonthier, C.
Groft, S.
Gut, I.
Hamosh, A.
Hieter, P.
Höhn, S.
Hurles, M.
Kaufmann, P.
Knoppers, B.
Krischer, J.
Macek, M.
Matthijs, G.
Olry, A.
Parker, S.
Paschall, J.
Philippakis, A.
Rehm, H.
Robinson, P.
Sham, P.
Stefanov, R.
Taruscio, D.
Unni, D.
Vanstone, M.
Zhang, F.
Brunner, H.
Bamshad, M.
Lochmüller, H.
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title_full International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title_fullStr International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title_full_unstemmed International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title_short International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
title_sort international cooperation to enable the diagnosis of all rare genetic diseases
url http://hdl.handle.net/20.500.11937/72942